Karen M. Matta

SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target.

M. Vitek, Joseph O. Moore, J. Gockerman, 2011, Blood.

The BMP antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms.

J. Klingensmith, Murim Choi, R. Stottmann, 2006, Developmental biology.

Perifosine treatment in chronic lymphocytic leukemia: results of a phase II clinical trial and in vitro studies

D. Brander, Joseph O. Moore, J. Gockerman, 2014, Leukemia & lymphoma.

Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia

M. Datto, C. Rehder, C. Decastro, 2012, Leukemia & lymphoma.